Last updated: August 5, 2024
Sponsor: Dynamic Light
Overall Status: Completed
Phase
N/A
Condition
Aneurysm
Brain Tumor
Brain Cancer
Treatment
Laser speckle contrast imaging (LSCI)
Clinical Study ID
NCT05305378
LSCI-NSURG-03
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Adults (18 years or older).
Size of craniotomy at least 2 cm.
Possibility of intraoperative ICGA.
Able to render written informed consent.
Women of child-bearing potential must have a negative pre-op pregnancy test.
Exclusion
Exclusion Criteria:
Patients unable to legally consent.
Patients with impaired cognitive function.
Study Design
Total Participants: 8
Treatment Group(s): 1
Primary Treatment: Laser speckle contrast imaging (LSCI)
Phase:
Study Start date:
April 20, 2022
Estimated Completion Date:
August 31, 2022
Study Description
Connect with a study center
Barrow Neurological Institute
Phoenix, Arizona 85013
United StatesSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.